| Retromer binding to FAM21 and the WASH complex is perturbed by the Parkinson disease-linked VPS35 (D620N) mutation IJ McGough, F Steinberg, D Jia, PA Barbuti, KJ McMillan, KJ Heesom, ... Current Biology 24 (14), 1670-1676, 2014 | 214 | 2014 |
| Stepwise, non-adherent differentiation of human pluripotent stem cells to generate basal forebrain cholinergic neurons via hedgehog signaling LA Crompton, ML Byrne, H Taylor, TL Kerrigan, G Bru-Mercier, JL Badger, ... Stem cell research 11 (3), 1206-1221, 2013 | 57 | 2013 |
| Mitochondrial and clearance impairment in p. D620N VPS35 patient‐derived neurons Z Hanss, SB Larsen, P Antony, P Mencke, F Massart, J Jarazo, ... Movement Disorders 36 (3), 704-715, 2021 | 43 | 2021 |
| Recent advances in the development of stem‐cell‐derived dopaminergic neuronal transplant therapies for Parkinson's disease PA Barbuti, RA Barker, P Brundin, S Przedborski, SM Papa, LV Kalia, ... Movement Disorders 36 (8), 1772-1780, 2021 | 33 | 2021 |
| A monolayer hiPSC culture system for autophagy/mitophagy studies in human dopaminergic neurons P Stathakos, N Jiménez-Moreno, LA Crompton, PA Nistor, JL Badger, ... Autophagy 17 (4), 855-871, 2021 | 21 | 2021 |
| Using high-content screening to generate single-cell gene-corrected patient-derived iPS clones reveals excess alpha-synuclein with familial Parkinson’s disease point mutation A30P P Barbuti, P Antony, B Santos, F Massart, G Cruciani, C Dording, J Arias, ... Cells 9 (9), 2065, 2020 | 20 | 2020 |
| Unraveling molecular mechanisms of THAP1 missense mutations in DYT6 dystonia F Cheng, M Walter, Z Wassouf, T Hentrich, N Casadei, J Schulze-Hentrich, ... Journal of Molecular Neuroscience 70, 999-1008, 2020 | 14 | 2020 |
| Mitochondria interaction networks show altered topological patterns in Parkinson’s disease M Zanin, BFR Santos, PMA Antony, C Berenguer-Escuder, SB Larsen, ... NPJ Systems Biology and Applications 6 (1), 38, 2020 | 12 | 2020 |
| Synaptic decline precedes dopaminergic neuronal loss in human midbrain organoids harboring a triplication of the SNCA gene J Modamio, C Saraiva, GG Giro, SL Nickels, J Jarazo, P Antony, P Barbuti, ... bioRxiv, 2021.07. 15.452499, 2021 | 9 | 2021 |
| Retromer dysfunction in amyotrophic lateral sclerosis EJ Pérez-Torres, I Utkina-Sosunova, V Mishra, P Barbuti, ... Proceedings of the National Academy of Sciences 119 (26), e2118755119, 2022 | 7 | 2022 |
| Induced pluripotent stem cell line (LCSBi001-A) derived from a patient with Parkinson's disease carrying the p. D620N mutation in VPS35 SB Larsen, Z Hanss, G Cruciani, F Massart, PA Barbuti, G Mellick, ... Stem Cell Research 45, 101776, 2020 | 7 | 2020 |
| Generation of two iPS cell lines (HIHDNDi001-A and HIHDNDi001-B) from a Parkinson’s disease patient carrying the heterozygous p. A30P mutation in SNCA PA Barbuti, BFR Santos, CM Dording, G Cruciani, F Massart, A Hummel, ... Stem Cell Research 48, 101951, 2020 | 6 | 2020 |
| DYT6 mutated THAP1 is a cell type dependent regulator of the SP1 family F Cheng, W Zheng, PA Barbuti, P Bonsi, C Liu, N Casadei, G Ponterio, ... Brain 145 (11), 3968-3984, 2022 | 5 | 2022 |
| IPSC-derived midbrain astrocytes from Parkinson’s disease patients carrying pathogenic SNCA mutations exhibit alpha-synuclein aggregation, mitochondrial … PA Barbuti, P Antony, G Novak, SB Larsen, C Berenguer-Escuder, ... bioRxiv, 2020.04. 27.053470, 2020 | 4 | 2020 |
| Intronic enhancers of the human SNCA gene predominantly regulate its expression in brain in vivo F Cheng, W Zheng, C Liu, PA Barbuti, L Yu-Taeger, N Casadei, ... Science Advances 8 (47), eabq6324, 2022 | 3 | 2022 |
| Gene-corrected p.A30P SNCA patient-derived isogenic neurons rescue neuronal branching and function PA Barbuti, J Ohnmacht, BFR Santos, PM Antony, F Massart, G Cruciani, ... Scientific Reports 11 (1), 21946, 2021 | 2 | 2021 |
| Gene-corrected Parkinson’s disease neurons show the A30P alpha-synuclein point mutation leads to reduced neuronal branching and function PA Barbuti, BFR Santos, PM Antony, F Massart, G Cruciani, CM Dording, ... BioRxiv, 2020.11. 05.369389, 2020 | 1 | 2020 |
| Using High-Content Screening Technology as a Tool to Generate Single-Cell Patient-Derived Gene-Corrected Isogenic iPS Clones for Parkinson’s Disease Research PA Barbuti, PM Antony, BFR Santos, F Massart, G Cruciani, CM Dording, ... Preprints, 2020 | 1 | 2020 |
| Stem Cell Therapy for Neurological Disorders: From Bench to Bedside PA Barbuti Stem Cell Therapy for Organ Failure, 41-70, 2014 | 1 | 2014 |
| Mitochondrial phenotype related to the A30P alpha-synuclein mutation as a patient-derived cellular model of Parkinson's disease B Santos, P Barbuti, P Antony, J Arias, A Hummel, J Schwamborn, ... MOVEMENT DISORDERS 33, S613-S613, 2018 | | 2018 |
